ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1527

Serum Inflammation Identifies Increased Risk of Frailty in Rheumatoid Arthritis

James S. Andrews1, Elizabeth R. Wahl2, Gabriela Schmajuk3, Edward H. Yelin4 and Patricia P. Katz5, 1Rheumatology, University of California San Francisco, San Francisco, CA, 2Medicine/Rheumatology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, 3San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, 4University of California, San Francisco, San Francisco, CA, 5Rheumatology, UCSF, SF, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: C-reactive protein (CRP), Inflammation, physical impairment and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Frailty has been defined as “an excess vulnerability to stressors, with reduced ability to maintain or regain homeostasis after a destabilizing event” 1.  Frailty is closely related to body composition and physical functioning, and is associated with increased risk of poor health outcomes including death.  Serum inflammation is associated with differences in body composition and physical functioning in the general population and individuals with chronic disease. The ability of serum markers of inflammation to identify increased frailty among individuals with rheumatoid arthritis (RA) is unknown.  This study tests whether serum erythrocyte sedimentation rate (ESR) and C-Reactive Protein (CRP) are associated with increased risk of frailty among men and women with RA. 

Methods: Participants were individuals in a longitudinal cohort with physician-documented RA.  All measures were collected during an in-person research visit.  ESR and high sensitivity CRP were assessed from blood samples using standard clinical assays.  Individuals with 3 or more of the following physical deficits were classified as frail1: 1) body mass index ≤ 18.5, 2) low grip strength (adjusted for sex and BMI, measured by handheld dynamometer), 3) severe fatigue (measured by the Fatigue Severity Inventory), 4) slow 4-meter walking speed (adjusted for sex and height), 5) low physical activity (measured by the International Physical Activity Questionnaire).  Individuals with 1 or 2 deficits were classified as “pre-frail”, and those with no deficits as “robust.” 1  Multinomial logistic regression analyses controlling for age, sex, smoking status, RA disease duration, prednisone use, tumor necrosis factor inhibitor use, appendicular lean mass, and pain modeled the effects of ESR and CRP on severity of frailty. 

Results: Of the 141 participants, 60% were female; mean age was 58 (±11) years, duration of RA was 19 (±11) years, ESR was 19 (±19) mm/h, and hsCRP was 5 (± 8) mg/L.  Sixteen participants (11%) were frail, 86 (61%) pre-frail, 22 (16%) robust, and 17 (12%) were missing grip strength data.  In adjusted models, higher ESR was associated with significantly increased risk of frailty (Table 1).  Similar trends were observed between CRP and risk of frailty, but did not reach statistical significance in adjusted models. 

Conclusion: Frailty and pre-frailty were common in our cohort of individuals with RA, with a greater prevalence than that of geriatric populations.  Serum levels of ESR were associated with approximately twice the risk of being frail or pre-frail compared to being robust.  CRP demonstrated similar effects on risk of frailty, though trends did not reach statistical significance.  These findings underscore the high burden of frailty among individuals with RA, and they may suggest a clinical role for serum ESR and CRP in identifying individuals with RA at greatest risk of frailty. 

 1Fried J Am Geriatr Soc 2001;56:M146

Table 1: Multinomial Logistic Regression Relative Risk Ratios (95% CIs) for the Effect of Serum Sedimentation Rate and C-Reactive Protein on Risk of Frailty Category among Individuals with RA

 

ESR

CRP

 

Unadjusted

Adjusted#

Unadjusted

Adjusted#

Frail

 

1.69

(0.94, 3.07)

2.56*

(1.16, 5.65)

1.49

(0.88, 2.52)

1.96+

(0.96, 4.03)

Pre-Frail

1.43

(0.95, 2.15)

1.92*

(1.05, 3.48)

1.26

(0.85, 1.86)

1.66+

(0.94, 2.94)

Robust

Reference

Reference

Reference

Reference

#Model is adjusted for age, sex, smoking status, disease duration, prednisone use, tumor necrosis factor inhibitor use, appendicular lean mass, and pain due to rheumatoid arthritis.

Frail= 3 or more physical deficits, Pre-frail= 1-2 physical deficits, Robust= 0 physical deficits (Fried LP et al., J Gerontol A Biol Sci Med Sci, 2001; 56:M146)

*p<0.05, +p<0.1


Disclosure: J. S. Andrews, None; E. R. Wahl, None; G. Schmajuk, None; E. H. Yelin, None; P. P. Katz, None.

To cite this abstract in AMA style:

Andrews JS, Wahl ER, Schmajuk G, Yelin EH, Katz PP. Serum Inflammation Identifies Increased Risk of Frailty in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/serum-inflammation-identifies-increased-risk-of-frailty-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-inflammation-identifies-increased-risk-of-frailty-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology